Emerging CAR T cells therapies: clinical landscape and patent technological routes.

Clicks: 348
ID: 67241
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #11 of 39 articles by views in human vaccines & immunotherapeutics

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The purpose of this study is to mine CAR-T patents and therapies under development, to design a landscape of the sector and to understand key therapy segments and their current trends. The study analyzed the entire market, consisting of 1624 patent families and 509 biologics under development, to depict an overview of the CAR-T therapies and their state of the art. Our results showed cutting-edge inventions, the major players, the dynamics of cooperation among institutions, the progress of the therapies' generation over the years and future innovation pathways. CAR-T therapies are transforming the current scenario for cancer treatment, and this study reveals the picture of what we can likely expect ahead in order to assist scientists at the academy and industry to improve their research strategies.
Reference Key
picancocastro2019emerginghuman Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Picanco-Castro, Virgínia;Gonçalves Pereira, Cristiano;Swiech, Kamilla;Ribeiro Malmegrim, Kelen Cristina;Tadeu Covas, Dimas;Silveira Porto, Geciane;
Journal human vaccines & immunotherapeutics
Year 2019
DOI
10.1080/21645515.2019.1689744
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.